[BXRX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BXRX] Baudax Bio, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 68.33%
YoY- -131.42%
Quarter Report
BXRX's Result
BXRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 310 400 76 0 0 -
PBT -9,249 29,434 -17,042 -7,325 -16,681 -13.69%
Tax 1,574 -2,893 -15,711 687 1,346 3.98%
NP -9,249 29,434 -17,042 -7,325 -16,681 -13.69%
Tax Rate - 9.83% - - - -
Total Cost 9,559 -29,034 17,118 7,325 16,681 -12.98%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -2,983.55 7,358.50 -22,423.68 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -5.70 446.40 -490.05 -1,096.89 -2,572.64 -78.28%
EPS Diluted -5.70 401.20 -490.05 -1,096.89 -2,572.64 -78.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.